Actavis’s Generics Linaclotide Receives Tentative Approval in US
19 May 2026 //
FDA
Aspiro’s Generics Isoproterenol HCl Receives Approval in US
18 May 2026 //
FDA
Quagen’s Generics Glycopyrrolate Receives Approval in US
18 May 2026 //
FDA
Jubilant Generics’ Generics Tadalafil Receives Approval in US
15 May 2026 //
FDA
Ascent’s Generics Clomiphene Citrate Receives Approval in US
15 May 2026 //
FDA
Zydus’ Generics Ammonium Lactate Receives Approval in US
15 May 2026 //
FDA
Dr Reddy’s Generics Phytonadione Receives Approval in US
15 May 2026 //
FDA
Dr Reddy’s Generics Venetoclax Receives Approval in US
15 May 2026 //
FDA
Astrazeneca Pharms’ Baxfendy Receives Approval in US
15 May 2026 //
FDA
Ionetix’s Generics Gallium Gozetotide Receives Approval in US
14 May 2026 //
FDA
Zydus’s Generics Ubrogepant Receives Tentative Approval in US
14 May 2026 //
FDA
Sandoz’s Generics Tivozanib Receives Tentative Approval in US
14 May 2026 //
FDA
Ionetix`s Gallium Ga-68 Gozetotide Receives US Approval
14 May 2026 //
FDA
Chiesi Farmaceutici’s Trimbow Receives Approval in US
14 May 2026 //
FDA
Stira’s Generics L-Glutamine Receives Approval in US
14 May 2026 //
FDA
FDC’s Generics Cefixime Receives Approval in US
14 May 2026 //
FDA
Caplin’s Generics Foscarnet Na Receives Approval in US
13 May 2026 //
FDA
Tamarang Sa`s Sugammadex Receives Tentative US Approval
13 May 2026 //
FDA
Beone Medicines’ Beqalzi Receives Approval in US
13 May 2026 //
FDA
Tamarang’s Generics Sugammadex Receives Tentative Approval in US
12 May 2026 //
FDA
Sandoz’s Generics Bempedoic Acid Receives Tentative Nod in US
12 May 2026 //
FDA
Umedica’s Generics Zolpidem Tartrate Receives Approval in US
12 May 2026 //
FDA
Centaur Pharma`s Dapagliflozin Gets Tentative US Approval
12 May 2026 //
FDA
Lupin’s Generics Famotidine Receives Approval in US
12 May 2026 //
FDA
Encube’s Generics Estradiol Receives Approval in US
11 May 2026 //
FDA
Mylan’s Generics Levetiracetam Receives Approval in US
08 May 2026 //
FDA
Inventia’s Generics Sitagliptin Receives Tentative Approval in US
07 May 2026 //
FDA
Dr. Reddy’s Generics Empagliflozin Receives Tentative Nod in US
07 May 2026 //
FDA
Lachman’s Dolutegravir, Lamivudin Receives Tentative Nod in US
07 May 2026 //
FDA
Micro’s Generics Brimonidine Tartrate Receives Approval in US
07 May 2026 //
FDA
Zydus’ Generics Hydrocortisone Sodium Receives Approval in US
07 May 2026 //
FDA
Accord Biopharma’s Biologics Ennumo Receives Approval in US
07 May 2026 //
FDA
I3 Pharms’ Generics Paliperidone Receives Approval in US
07 May 2026 //
FDA
Centaur’s Generics Dapagliflozin Receives Tentative Nod in US
06 May 2026 //
FDA
Sandoz’s Generics Vasopressin Receives Approval in US
06 May 2026 //
FDA
Zhejiang Novous’s Generics Voriconazole Receives Approval in US
05 May 2026 //
FDA
Yichang Humanwell’s Generics Bupropion Receives Approval in US
04 May 2026 //
FDA
Caplin’s Generics Calcium Gluconate Receives Approval in US
04 May 2026 //
FDA
Hetero’s Generics Sodium Sulfate Receives Tentative Nod in US
01 May 2026 //
FDA
Apotex’s Evdi Receives Approval in US
01 May 2026 //
FDA
Deva Holding’ Generics Mirabegron Receives Approval in US
01 May 2026 //
FDA
Arvinas Operations’ Veppanu Receives Approval in US
01 May 2026 //
FDA
Bicoon’s Generics Sitagliptin Receives Tentative Approval in US
01 May 2026 //
FDA
Micro’s Generics Torsemide Receives Approval in US
01 May 2026 //
FDA
Incyte Oration’s Jakafi Xr Receives Approval in US
01 May 2026 //
FDA
Ipca’s Generics Propranolol HCl Receives Approval in US
01 May 2026 //
FDA
Eli Lilly Canada`s Kisunla Approved in Canada
30 Apr 2026 //
HEALTH CANADA
Aizant’s Generics Eltrombopag Olamine Receives Approval in US
28 Apr 2026 //
FDA
Sun Pharma Canada’s Generics Doxepin HCl Receives Approval in US
28 Apr 2026 //
FDA
Gan & Lee Pharma’s Dazparda Receives Approval in Europe
27 Apr 2026 //
EMA
Gedeon Richter’s Tuyory Receives Approval in Europe
27 Apr 2026 //
EMA
Tanabe Pharma’s Onerij Receives Approval in Europe
27 Apr 2026 //
EMA
X4 Pharma’s Xolermdi Receives Approval in Europe
27 Apr 2026 //
EMA
Micro’s Generics Ticagrelor Receives Approval in US
27 Apr 2026 //
FDA
Astrazeneca’s Biologics Saphnelo Receives Approval in US
24 Apr 2026 //
FDA
Alembic’s Generics Fingolimod HCl Receives Approval in US
24 Apr 2026 //
FDA
Crinetics Pharma’s Palsonify Receives Approval in Europe
23 Apr 2026 //
EMA
Novartis’s Rhapsido Receives Approval in Europe
23 Apr 2026 //
EMA
Navinta’s Generics Glycerol Phenylbutyrate Receive Approval in US
23 Apr 2026 //
FDA
Teva’ Generics Budesonide & Formoterol Receives Approval in US
23 Apr 2026 //
FDA

Market Place
Sourcing Support